Considered the most fatal cancers, Lung cancer presents no symptoms until it is well advanced. This reduces the rate of treatment success. In the United States, more than 170,000 Americans are diagnosed each year. Smoking, as well as with other environmental risks is a causative agent to contract a lung cancer. Surprisingly, causes multiple cancer among women than even the breast cancer deaths.
Traditional approaches to lung cancer treatment includes chemotherapy, surgery and radiation therapy.One or more of these treatments are often used in combinaison.Il is a growing number of new approaches in development, thus.
By definition, are key processes for the strong lung cancer, chemotherapy, treatment by drugs and one of the main procedures used surgery, indicated when the cancer is localized, today; to prevent its spread (metastasis); radiation and x-rays, which are sometimes used in combination with surgery or chemotherapy to kill cancer cells.
Slightly more recent immunotherapy treatment is used to stimulate the immune system of the individual course to combat the disease more.
Among the promising alternative therapies, controlled and acidic amino Therapy (CAAT) was developed and studied at the Institute of John A.P. cancer.Cette procedure research involves the deprivation of carbohydrates and proteins. Mr. Marco Rabinwitz at the National Cancer Institute and Dr. Albert Lorincz Chicago University conducted research to support CAAT and its effectiveness in the treatment of cancer. Briefly, CAAT has specific protocols of diet and supplements amino acids that are scientifically formulated. This combination works at to hinder the development and proliferation of cancer cells.
In the treatment of chemotherapy, there are some new drugs that work differently than traditional chemical agents.Treatment approved 4 years ago, Gefitinib is administered in the form of tablets.Specifically, target and blocks an enzyme which stimulates the growth of tumour cells and the propagation.Un another new chemotherapy treatment involves a combination of two chemical/biochemical agents - Bevacizumab and Erlotinib.Always in the study phase, this treatment is show promising results.Erlotinib works inside the cancer cell.It prevents the signals that trigger cancer.Bevacizumab, antibodies, features outside of the cell cancer, cell growth against the growth of blood vessels that could feed the tumor.
Photodynamic Therapy or PDT is yet another new traitement.PDT a (photosensitizer) Phototoxic drug is administered and followed by exposure to light, either conventional or laser targeting tumour cancéreuse.Méthode approved an FDA, its current application is cancerous lesions solides.Dans PDT treatment, various immune cells play a key role in the effectiveness of the tumor reduction and eradication, installations, such as BC cancer research centre study using PDT and immunotherapy in concert, on immunotherapy to catalyze the PDT.
With cancer is the most deadly lung and covering a wide range of population, the search for new and more effective treatments promising continue.Plus are those that target specific mechanisms of cell growth of cancer.La research fundamental, conducted over the years, is now providing the background to the development of more effective and less devastating lung cancer treatments.
